Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

4.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compressive Coronary Hematoma Treated With Stenting: From Early Malapposition to 9-Year Recovery in Systemic Disease.

JACC. Case reports·2026
Same author

Missed Opportunity for Fibrinolysis in ST-Segment-Elevation Myocardial Infarction: The Nationwide France-PCI Registry.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices: A Prospective Randomized Study.

Journal of the American College of Cardiology·2026
Same author

Selective Use of Thromboaspiration in STEMI: CMR Evidence Against Routine Practice.

The American journal of cardiology·2026
Same author

Cardioprotective effects of the extracellular chaperone clusterin in acute myocardial infarction.

European journal of clinical investigation·2025
Same author

Rationale and design of the FRENch CoHort of myocardial Infarction Evaluation (FRENCHIE) study.

Archives of cardiovascular diseases·2024
Same journal

Five-year outcomes of glucagon-like peptide-1 agonists in hypertrophic cardiomyopathy: A population-based retrospective study.

Journal of cardiology·2026
Same journal

Transitional Care for Pediatric Cardiomyopathy Patients in Japan: A Nationwide Survey of Current Practices and Challenges.

Journal of cardiology·2026
Same journal

Neutrophil-to-lymphocyte ratio in patients with low-flow aortic stenosis undergoing transcatheter aortic valve implantation.

Journal of cardiology·2026
Same journal

Cardiovascular and limb outcomes with SGLT2 inhibitors in patients with diabetes following peripheral endovascular therapy.

Journal of cardiology·2026
Same journal

Integrated interpretation of exercise electrocardiography and cardiopulmonary exercise testing for detection of significant coronary artery stenosis.

Journal of cardiology·2026
Same journal

Author's reply to "Comment on 'Cardio-ankle vascular index as a screening tool for coronary artery disease in patients with metabolic dysfunction-associated steatotic liver disease'".

Journal of cardiology·2026
See all related articles

Related Experiment Video

Updated: Apr 16, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.9K

Remote ischemic conditioning: Current clinical perspectives.

Sophie Le Page1, Fabrice Prunier1

  • 1L'UNAM Université, Université d'Angers, EA 3860 Cardioprotection, Remodelage et Thrombose, CHU Angers, Service de Cardiologie, Angers, France.

Journal of Cardiology
|March 7, 2015
PubMed
Summary
This summary is machine-generated.

Remote ischemic conditioning (RIC) is a method where brief, repeated blood flow interruptions protect distant organs. While promising for reducing heart injury, its clinical benefits require more research, with large trials ongoing.

Keywords:
CardioprotectionConditioningIschemia-reperfusion injury

More Related Videos

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
07:46

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Published on: May 9, 2013

30.4K
Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

8.1K

Related Experiment Videos

Last Updated: Apr 16, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.9K
Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
07:46

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Published on: May 9, 2013

30.4K
Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

8.1K

Area of Science:

  • Cardiovascular Science
  • Nephrology
  • Neurology

Background:

  • Remote ischemic conditioning (RIC) involves inducing brief ischemia/reperfusion in one area to protect another.
  • RIC is typically applied using a blood pressure cuff on a limb.
  • Initial research focused on RIC's effect on myocardial injury biomarkers.

Purpose of the Study:

  • To review the current evidence on remote ischemic conditioning.
  • To explore RIC's application beyond cardiac protection, including kidneys and brain.
  • To assess the readiness of RIC for widespread clinical adoption.

Main Methods:

  • Literature review of studies investigating RIC.
  • Analysis of clinical trials evaluating RIC for various organ protection.
  • Examination of RIC's mechanism and application techniques.

Main Results:

  • RIC shows potential in protecting distant organs, including the heart, kidneys, and brain.
  • Current studies are underpowered to confirm RIC's impact on clinical outcomes.
  • Large Phase III trials are investigating major clinical endpoints.

Conclusions:

  • RIC is a promising, non-invasive organ protection strategy.
  • Further high-powered clinical trials are essential to establish RIC's efficacy.
  • The future clinical role of RIC depends on outcomes from ongoing large-scale trials.